These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12581024)

  • 1. Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer.
    Ong E; Joseph JV; Bramwell SP; Haites NE
    BJU Int; 2003 Feb; 91(3):297. PubMed ID: 12581024
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 4. Upper urinary tract carcinoma in Lynch syndrome cases.
    Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
    J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
    Chen PC; Chen WC; Chao SC; Lin BW; Lin SC; Chen CJ; Lee JC
    J Surg Oncol; 2012 Mar; 105(3):329-30. PubMed ID: 21882197
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial carcinoma of ureters and other genitourinary organs.
    Marchetto D; Li FP; Henson DE
    J Urol; 1983 Oct; 130(4):772-3. PubMed ID: 6887416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.
    Jasperson KW; Blazer KR; Lowstuter K; Weitzel JN
    Fam Cancer; 2008; 7(4):281-5. PubMed ID: 18176851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
    Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
    BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
    Tzen CY; Wu CJ; Huang ZD; Wu TY
    Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metachronous bilateral ureteral cancer in patient with hereditaly nonpolyposis colorectal cancer].
    Yamamoto M; Kashiwai H; Hirata N; Matsuki H; Shimizu K; Tanaka N; Ozono S
    Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):63-6. PubMed ID: 14978944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
    Cussenot O; Davin JL
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
    Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
    Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Malats N; Real FX
    Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Burger M
    Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial transitional cell carcinoma of the bladder.
    McCullough DL; Lamma DL; McLaughlin AP; Gittes RF
    J Urol; 1975 May; 113(5):629-35. PubMed ID: 1127804
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial urinary bladder cancer.
    Purtilo DT; McCarthy B; Yang JP; Friedell GH
    Semin Oncol; 1979 Jun; 6(2):254-6. PubMed ID: 482963
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Kirkali Z
    J Urol; 1999 Mar; 161(3):926. PubMed ID: 10022724
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial transitional cell carcinoma and the Lynch syndrome II.
    Greenland JE; Weston PM; Wallace DM
    Br J Urol; 1993 Aug; 72(2):177-80. PubMed ID: 8402022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.